Global Innovative Platforms Inc (GIPL)
Global Innovative Platforms Inc is a common stock listing on OTC Markets under the symbol GIPL. The company develops breath-testing technologies intended to help detect disease and support treatment, including a Heartworm breath test with a breath collection device for collecting shallow breath samples. Its product and technology portfolio also includes the VOCAM Plus and FROG gas chromatography platforms, along with AI software used for breath and air analysis. The company was incorporated in 2020 and is based in Sanford, Florida. It previously operated under the name Canning Str Corp. before adopting its current name in September 2021.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GIPL
|
$0.25
|
-50.0% Downside
|
Overvalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
December 30, 2026
|
46.8x
|
132.9x
|
24.876 M
|
24.631 M
|
0.0%
|
41.8%
|
1,908.0
|
67.7%
|
